BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38032828)

  • 1. The Postmenopausal Vaginal Microbiome and Genitourinary Syndrome of Menopause.
    Micks E; Reed SD; Mitchell C
    Clin Obstet Gynecol; 2024 Mar; 67(1):79-88. PubMed ID: 38032828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation.
    Mitchell CM; Ma N; Mitchell AJ; Wu MC; Valint DJ; Proll S; Reed SD; Guthrie KA; Lacroix AZ; Larson JC; Pepin R; Raftery D; Fredricks DN; Srinivasan S
    Am J Obstet Gynecol; 2021 Aug; 225(2):159.e1-159.e15. PubMed ID: 33675793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between the vaginal microbiota and genitourinary syndrome of menopause symptoms in postmenopausal women: the Study of Women's Health Across the Nation.
    Waetjen LE; Crawford SL; Gajer P; Brooks MM; Gold EB; Reed BD; Hess R; Ravel J
    Menopause; 2023 Nov; 30(11):1073-1084. PubMed ID: 37788422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Local Estrogen on the Urogenital Microbiome in Genitourinary Syndrome of Menopause: A Randomized-Controlled Trial.
    Lillemon JN; Karstens L; Nardos R; Garg B; Boniface ER; Gregory WT
    Female Pelvic Med Reconstr Surg; 2022 Jun; 28(6):e157-e162. PubMed ID: 35420551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
    The NAMS 2020 GSM Position Statement Editorial Panel
    Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Vaginal Microbiota With Signs and Symptoms of the Genitourinary Syndrome of Menopause Across Reproductive Stages.
    Shardell M; Gravitt PE; Burke AE; Ravel J; Brotman RM
    J Gerontol A Biol Sci Med Sci; 2021 Aug; 76(9):1542-1550. PubMed ID: 33903897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the genitourinary syndrome of menopause.
    Palacios S; Mejía A; Neyro JL
    Climacteric; 2015; 18 Suppl 1():23-9. PubMed ID: 26366797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.
    Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genitourinary Syndrome of Menopause among Postmenopausal Women in a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Ojha N; Bista KD; Bajracharya S; Katuwal N
    JNMA J Nepal Med Assoc; 2022 Feb; 60(246):126-131. PubMed ID: 35210630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between improvement in genitourinary symptoms of menopause and changes in the vaginal ecosystem.
    Mitchell CM; Srinivasan S; Plantinga A; Wu MC; Reed SD; Guthrie KA; LaCroix AZ; Fiedler T; Munch M; Liu C; Hoffman NG; Blair IA; Newton K; Freeman EW; Joffe H; Cohen L; Fredricks DN
    Menopause; 2018 May; 25(5):500-507. PubMed ID: 29206774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Hocké C; Diaz M; Bernard V; Frantz S; Lambert M; Mathieu C; Grellety-Cherbero M
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):394-413. PubMed ID: 33757926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial.
    Gueldini de Moraes AV; Costa-Paiva L; da Costa Machado H; Maciel TF; Mariano FV; Pedro AO
    Menopause; 2024 Apr; 31(4):288-302. PubMed ID: 38412393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microbiota in the management of genitourinary syndrome of menopause.
    Stabile G; Topouzova GA; De Seta F
    Climacteric; 2023 Aug; 26(4):353-360. PubMed ID: 37366082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genitourinary syndrome of the menopause--dawn of a new era?
    Panay N
    Climacteric; 2015; 18 Suppl 1():13-7. PubMed ID: 26366795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy.
    Pérez-López FR; Vieira-Baptista P; Phillips N; Cohen-Sacher B; Fialho SCAV; Stockdale CK
    Gynecol Endocrinol; 2021 Aug; 37(8):740-745. PubMed ID: 34036849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms.
    Thomas-White K; Taege S; Limeira R; Brincat C; Joyce C; Hilt EE; Mac-Daniel L; Radek KA; Brubaker L; Mueller ER; Wolfe AJ
    Am J Obstet Gynecol; 2020 Nov; 223(5):727.e1-727.e11. PubMed ID: 32791124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
    Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
    Menopause; 2016 Mar; 23(3):243-56. PubMed ID: 26731686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of genitourinary syndrome of menopause: number, severity, and frequency of vulvovaginal discomfort symptoms in women enrolled in a randomized trial evaluating treatment for genitourinary syndrome of menopause.
    Mitchell CM; Larson JC; Reed SD; Guthrie KA
    Menopause; 2023 Aug; 30(8):791-797. PubMed ID: 37402281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse.
    Rahn DD; Richter HE; Sung VW; Hynan LS; Pruszynski JE
    Am J Obstet Gynecol; 2023 Sep; 229(3):309.e1-309.e10. PubMed ID: 37244454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.